P&G Crest Whitestrips Patents Stand Up To ‘Indefiniteness’ Challenge
This article was originally published in The Rose Sheet
Executive Summary
P&G prevails in U.S. district court arguing that three private-label tooth-whitening-strip firms infringed three of its patents for Crest Whitestrips. The defendants plan to appeal the ruling against their motion that two of P&G’s patents are invalid.
You may also be interested in...
'Slow-Growth' Global Trend Shakes Up P&G Product Strategy Start To Finish
P&G’s health care segment advanced 4% in the third quarter to $1.84bn, but sales declined for its other business units, a trend the firm sees worldwide across consumer industries. CFO Jon Moeller unveils the firm’s “irresistible superiority” product development strategy to counter slower global consumer spending.
'Slow-Growth' Global Trend Shakes Up P&G Product Strategy Start To Finish
P&G’s health care segment advanced 4% in the third quarter to $1.84bn, but sales declined for its other business units, a trend the firm sees worldwide across consumer industries. CFO Jon Moeller unveils the firm’s “irresistible superiority” product development strategy to counter slower global consumer spending.
In Brief
Rockline Industries recalls baby and personal wipes due to mold contamination; Symrise strengthens its position in West Africa with new Nigerian subsidiary; P&G’s operations are suspended in Argentina due to alleged tax evasion. More news in brief.